2
Clinical Trials associated with SRK-001A Randomized, Placebo-Controlled, Double-blind, Multiple Dose, Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics Following Intravenous Administration of SRK-001 in Healthy Participants
The purpose of the study is to evaluate safety, tolerability, and pharmacokinetics (PK) of SRK-001 in Healthy Participants.
/ CompletedNot Applicable A Randomized, Placebo-Controlled, Double-blind, Multiple Dose, Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics Following Intravenous Administration of SRK-001 in Healthy Participants. - Multiple Dose Study on Safety, Tolerability, and PK of SRK-001
100 Clinical Results associated with SRK-001
100 Translational Medicine associated with SRK-001
100 Patents (Medical) associated with SRK-001
100 Deals associated with SRK-001